Chen, Tony Hsiu HsiTony Hsiu HsiChenLiu P.F.C.Tsai H.-H.RUOH-FANG YENHORNG-HUEI LIOU2020-09-232020-09-2320161352-0504https://scholars.lib.ntu.edu.tw/handle/123456789/514441[SDGs]SDG3interferon; antiviral therapy; disease association; hepatitis C; human; incidence; Letter; nerve cell necrosis; Parkinson disease; priority journal; risk factor; Taiwanese; treatment outcomeRe: Wangensteen et al. of a letter on ‘Hepatitis C virus infection: a risk factor for Parkinson's disease.'letter10.1111/jvh.12521269135882-s2.0-84975112966